Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 11.420\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCCn1c(SCC(=O)Nc2cccc(S(=O)(=O)N3CCCC3)c2)n[nH]c1=O
(b) CC(=O)O.c1ccc2c(c1)NC1(CCCCCC1)n1c-2nc2ccccc21
Answer: a. CCCn1c(SCC(=O)Nc2cccc(S(=O)(=O)N3CCCC3)c2)n[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCC(=O)Nc2cccc(S(=O)(=O)N3CCCC3)c2)n[nH]c1=O
CCCn1c(SCC(=O)Nc2cccc(S(=O)(=O)N3CCCC3)c2)n[nH]c1=O
2-[(5-oxo-4-propyl-1H-1,2,4-triazol-3-yl)sulfanyl]-N-(3-pyrrolidin-1-ylsulfonylphenyl)acetamide